| 发明名称 |
HIGH-AFFINITY HCV T CELL RECEPTOR |
| 摘要 |
Provided is a T cell receptor(TCR), combining with KLVALGINAV-HLA-A 2 compound and comprising a TCR α variable domain and/or TCR β variable domain. Also provided is a fusion of a TCR and a therapeutic agent. The TCR can be used separately, and in combination with the therapeutic agent, for target presenting of HCV infection cells of a KLVALGINAV-HLA-A 2 compound. |
| 申请公布号 |
WO2015192757(A1) |
申请公布日期 |
2015.12.23 |
| 申请号 |
WO2015CN81491 |
申请日期 |
2015.06.15 |
| 申请人 |
GUANGZHOU XIANGXUE PHARMACEUTICAL CO.LTD;LI, YI |
发明人 |
LI, YI;CHEN, LEI;ZHANG, JIANBING |
| 分类号 |
C07K14/725;A61K38/17;A61P31/14;A61P35/00;C07K19/00;C12N5/10;C12N15/12;C12N15/63 |
主分类号 |
C07K14/725 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
